Gross Margin

With a new name, CEO, and a $1.2B revenue base, Circle8 is pivoting from staffing to a global tech powerhouse. Can its 'one-stop-shop' model win?

The milestone isn't just a number; it's a blueprint for competitive advantage. A deep dive into how decades of innovation now position NETSCOUT at the heart of AI-driven security and 5G assurance.

Facing a disconnect between its growing operations and its market price, Sucro Limited is reviewing its strategy. What does this move reveal about the future of sugar?

Copart announced a CEO transition, bringing back former leader Jay Adair. We analyze the strategic calculus behind this move amidst record success.

A $49M government-backed loan sends a Connecticut company’s stock soaring. Is this the future of American clean energy or a risky taxpayer-funded gamble?

German design icon LAMY partners with Anoto's inq, a strategic move blending heritage with tech to redefine the premium smartpen market and fuel global growth.

The world’s first autonomous mining IPO isn't just about trucks; it's a test of physical AI, a sign of China's industrial might, and a major bet by global finance.

As Aritzia prepares its Q1 FY27 results, all eyes are on whether the fashion house can sustain its meteoric growth and defy a turbulent retail landscape.

An institutional investor just paid a 25% premium for VCI Global stock. We go beyond the headline to unpack the AI platform that commanded this confidence.

Verano's upcoming Q2 report is a key indicator for the cannabis sector. We look at the strategic moves, from stock splits to rescheduling, setting the stage.

As FormFactor joins the Russell 1000, we decode the 'Russell Effect' and the growth signals that propelled this key semiconductor supplier to new heights.

Replenish Nutrients is partnering with Hutterite colonies to build a decentralized production network. Is this a new model for capital-light industrial growth?

Incoming Nuwellis CEO Mike McCormick lays out a bold growth plan targeting critically ill children, but a closer look reveals a precarious financial balancing act.

Bionano Genomics brings back OGM pioneer Dr. Alex Hastie as CSO. It's a strategic move to accelerate clinical adoption and restore investor confidence.

Amid a stock surge, Glass House Brands forces a warrant exercise, a strategic move to inject cash and clean its books for a potential major exchange listing.

As Bassett Furniture preps its Q2 earnings call, investors watch closely. Can its hybrid retail model weather a weak housing market and shifting spending?

With its U.S. launch underway, Nyxoah is betting its innovative Genio system can unseat an industry giant. But can it chart a path to profitability?

NVE Corporation names a technology expert its next CEO and expands its board, signaling a strategic blend of continuity and new expertise for its next chapter.

Intellicheck’s entry into the Russell 2000 validates its growth. But what does this mean for investors and the broader fight against digital identity fraud?

Middlefield's new Discovery 2026 IPO offers a 100% tax deduction by investing in Canadian gold miners. But is this tax-savvy play worth the inherent risk?